Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LNCAP CELLS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 116 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buchanan, G; Greenberg, NM; Scher, HI; Harris, JM; Marshall, VR; Tilley, WD
      Collocation of androgen receptor gene mutations in prostate cancer

      CLINICAL CANCER RESEARCH
    2. Hsieh, TC; Wu, JM
      Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitivehuman prostate cancer cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    3. Avila, DM; Zoppi, S; McPhaul, MJ
      The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    4. Buchanan, G; Yang, MO; Harris, JM; Nahm, HS; Han, GZ; Moore, N; Bentel, JM; Matusik, RJ; Horsfall, DJ; Marshall, VR; Greenberg, NM; Tilley, WD
      Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function

      MOLECULAR ENDOCRINOLOGY
    5. Bramlett, KS; Dits, NFJ; Sui, XM; Jorge, MC; Zhu, X; Jenster, G
      Repression of androgen-regulated gene expression by dominant negative androgen receptors

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    6. Denmeade, SR; Sokoll, LJ; Chan, DW; Khan, SR; Isaacs, JT
      Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostatecancer xenograft models

      PROSTATE
    7. Chlenski, A; Nakashiro, K; Ketels, KV; Korovaitseva, GI; Oyasu, R
      Androgen receptor expression in androgen independent prostate cancer cell lines

      PROSTATE
    8. Gregory, CW; Johnson, RT; Presnell, SC; Mohler, JL; French, FS
      Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft

      JOURNAL OF ANDROLOGY
    9. Sanders, JL; Chattopadhyay, N; Kifor, O; Yamaguchi, T; Brown, EM
      Ca2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    10. Kelloff, GJ; Lieberman, R; Seele, VE; Boone, CM; Lubet, RA; Kopelovich, L; Malone, WA; Crowell, JA; Higley, HR; Sigman, CC
      Acents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

      UROLOGY
    11. Coffey, RNT; Watson, RWG; Fitzpatrick, JM
      Signaling for the caspases: Their role in prostate cell apoptosis

      JOURNAL OF UROLOGY
    12. Pinto, JT; Rivlin, RS
      Antiproliferative effects of allium derivatives from garlic

      JOURNAL OF NUTRITION
    13. Tomura, A; Goto, K; Morinaga, H; Nomura, M; Okabe, T; Yanase, T; Takayanagi, R; Nawata, H
      The subnuclear three-dimensional image analysis of androgen receptor fusedto green fluorescence protein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    14. Xu, LL; Su, YP; Labiche, R; Segawa, T; Shanmugam, N; McLeod, DG; Moul, JW; Srivastava, S
      Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes

      INTERNATIONAL JOURNAL OF CANCER
    15. Jacquinet, E; Rao, NV; Rao, GV; Wang, ZM; Albertine, KH; Hoidal, JR
      Cloning and characterization of the cDNA and gene for human epitheliasin

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    16. Wang, LG; Ossowski, L; Ferrari, AC
      Overexpressed androgen receptor linked to p21(WAF1) silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line

      CANCER RESEARCH
    17. Cinar, B; Koeneman, KS; Edlund, M; Prins, GS; Zhau, HE; Chung, LWK
      Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line

      CANCER RESEARCH
    18. Kimura, K; Markowski, M; Bowen, C; Gelmann, EP
      Androgen blocks apoptosis of hormone-dependent prostate cancer cells

      CANCER RESEARCH
    19. Gregory, CW; He, B; Johnson, RT; Ford, OH; Mohler, JL; French, FS; Wilson, EM
      A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy

      CANCER RESEARCH
    20. Peng, JB; Zhuang, LY; Berger, UV; Adam, RM; Williams, BJ; Brown, EM; Hediger, MA; Freeman, MR
      CaT1 expression correlates with tumor grade in prostate cancer

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    21. Andriani, F; Nan, B; Yu, J; Li, XY; Weigel, NL; McPhaul, MJ; Kasper, S; Kagawa, S; Fang, BL; Matusik, RJ; Denner, L; Marcelli, M
      Use of the probasin promoter ARR(2)PB to express Bax in androgen receptor-positive prostate cancer cells

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    22. Tso, CL; McBride, WH; Sun, JR; Patel, B; Tsui, KH; Paik, SH; Gitlitz, B; Caliliw, R; van Ophoven, A; Wu, L; deKernion, J; Belldegrun, A
      Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells

      CANCER JOURNAL
    23. Gnanapragasam, VJ; Robson, CN; Leung, HY; Neal, DE
      Androgen receptor signalling in the prostate

      BJU INTERNATIONAL
    24. Wang, CH; Young, WJ; Chang, CS
      Isolation and characterization of the androgen receptor mutants with divergent transcriptional activity in response to hydroxyflutamide

      ENDOCRINE
    25. Amanatullah, DF; Reutens, AT; Zafonte, BT; Fu, MF; Mani, S; Pestell, RG
      Cell-cycle dysregulation and the molecular mechanisms of prostate cancer

      FRONTIERS IN BIOSCIENCE
    26. Zhao, XY; Malloy, PJ; Krishnan, AV; Swami, S; Navone, NM; Peehl, DM; Feldman, D
      Glucocorticoids can promote androgen-independent growth of prostate cancercells through a mutated androgen receptor

      NATURE MEDICINE
    27. Xia, SJ; Hao, GY; Tang, XD
      Androgen receptor isoforms in human and rat prostate

      ASIAN JOURNAL OF ANDROLOGY
    28. Slusher, BS; Tiffany, CW; Merion, A; Lapidus, RG; Jackson, PF
      Suramin potently inhibits the enzymatic activity of PSM

      PROSTATE
    29. Soda, H; Raymond, E; Sharma, S; Lawrence, R; Davidson, K; Oka, M; Kohno, S; Izbicka, E; Von Hoff, DD
      Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro

      PROSTATE
    30. Fronsdal, K; Engedal, N; Saatcioglu, F
      Efficient DNA-mediated gene transfer into prostate cancer cell line LNCaP

      PROSTATE
    31. El Etreby, MF; Liang, YY; Johnson, MH; Lewis, RW
      Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice

      PROSTATE
    32. Hsieh, TC; Wu, JM
      Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism

      ANTICANCER RESEARCH
    33. Hobisch, A; Hoffmann, J; Lambrinidis, L; Eder, IE; Bartsch, G; Klocker, H; Culig, Z
      Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer model

      UROLOGIA INTERNATIONALIS
    34. Holleran, JL; Miller, CJ; Culp, LA
      Tracking micrometastasis to multiple organs with lacZ-tagged CWR22R prostate carcinoma cells

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    35. Zhao, XY; Peehl, DM; Navone, NM; Feldman, D
      1 alpha,25-dihydroxyvitamin D-3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms

      ENDOCRINOLOGY
    36. Long, BJ; Grigoryev, DN; Nnane, IP; Liu, Y; Ling, YZ; Brodie, AM
      Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer

      CANCER RESEARCH
    37. Sadar, MD; Gleave, ME
      Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells

      CANCER RESEARCH
    38. Truica, CI; Byers, S; Gelmann, EP
      beta-catenin affects androgen receptor transcriptional activity and ligandspecificity

      CANCER RESEARCH
    39. Nava, VE; Cuvillier, O; Edsall, LC; Kimura, K; Milstien, S; Gelmann, EP; Spiegel, S
      Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells

      CANCER RESEARCH
    40. van Schaik, RHN; Wierikx, CDJ; Timmerman, MA; Oomen, MH; van Weerden, WM; van der Kwast, TH; van Steenbrugge, GJ; de Jong, FH
      Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues

      BRITISH JOURNAL OF CANCER
    41. Tong, M; Tai, HH
      Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    42. Skryma, R; van Coppenolle, F; Dufy-Barbe, L; Dufy, B; Prevarskaya, N
      Characterization of Ca2+-inhibited potassium channels in the LNCaP human prostate cancer cell line

      RECEPTORS & CHANNELS
    43. Geck, P; Szelei, J; Jimenez, J; Sonnenschein, C; Soto, AM
      Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    44. Dixon, SC; Kruger, EA; Bauer, KS; Figg, WD
      Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    45. Barbier, O; Belanger, A; Hum, DW
      Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C-19 steroid-conjugating protein

      BIOCHEMICAL JOURNAL
    46. Sinha, AA; Quast, BJ; Reddy, PK; Elson, MK; Wilson, MJ
      Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2 '-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice

      ANTICANCER RESEARCH
    47. Blutt, SE; Weigel, NL
      Vitamin D and prostate cancer

      PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE
    48. Zi, ZL; Agarwal, R
      Silibinin decreases prostate-specific antigen with cell growth inhibition via G(1) arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    49. Sadar, MD
      Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

      JOURNAL OF BIOLOGICAL CHEMISTRY
    50. Yeap, BB; Krueger, RG; Leedman, PJ
      Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells

      ENDOCRINOLOGY
    51. Zhang, SB; Hsieh, ML; Zhu, W; Klee, GG; Tindall, DJ; Young, CYF
      Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression

      ENDOCRINOLOGY
    52. McPherson, SJ; Mellor, SL; Wang, H; Evans, LW; Groome, NP; Risbridger, GP
      Expression of activin A and follistatin core proteins by human prostate tumor cell lines

      ENDOCRINOLOGY
    53. Lapointe, J; Labrie, C
      Identification and cloning of a novel androgen-responsive gene, uridine diphosphoglucose dehydrogenase, in human breast cancer cells

      ENDOCRINOLOGY
    54. Taplin, ME; Bubley, GJ; Ko, YJ; Small, EJ; Upton, M; Rajeshkumar, B; Balk, SP
      Selection for androgen receptor mutations in prostate cancers treated withandrogen antagonist

      CANCER RESEARCH
    55. Grigoryev, DN; Long, BJ; Nnane, IP; Njar, VCO; Liu, Y; Brodie, AMH
      Effects of new 17 alpha-hydroxylase/C-17,C-20-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo

      BRITISH JOURNAL OF CANCER
    56. Culig, Z; Hoffmann, J; Erdel, M; Eder, IE; Hobisch, A; Hittmair, A; Bartsch, G; Utermann, G; Schneider, MR; Parczyk, K; Klocker, H
      Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

      BRITISH JOURNAL OF CANCER
    57. Wang, LG; Liu, XM; Kreis, W; Budman, DR
      Phosphorylation dephosphorylation of androgen receptor as a determinant ofandrogen agonistic or antagonistic activity

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    58. BLANCHERE M; BERTHAUT I; PORTOIS MC; MESTAYER C; MOWSZOWICZ I
      HORMONAL-REGULATION OF THE ANDROGEN RECEPTOR EXPRESSION IN HUMAN PROSTATIC CELLS IN CULTURE

      Journal of steroid biochemistry and molecular biology
    59. PENTYALA SN; WHYARD TC; WALTZER WC; MEEK AG; HOD Y
      ANDROGEN INDUCTION OF UROKINASE GENE-EXPRESSION IN LNCAP CELLS IS DEPENDENT ON THEIR INTERACTION WITH THE EXTRACELLULAR-MATRIX

      Cancer letters
    60. Hanazono, M; Moro, K; Nakagawa, E; Tomooka, Y
      ICI 182,780 stimulates the growth of a uterine cell line derived from p53-deficient mice

      ZOOLOGICAL SCIENCE
    61. HANAZONO M; NAKAGAWA E; AIZAWA S; TOMOOKA Y
      ESTABLISHMENT OF PROSTATIC CELL-LINE PRO9AD FROM A P53-DEFICIENT MOUSE

      The Prostate
    62. NEGRICESI P; POLETTI A; COLCIAGO A; MAGNI P; MARTINI P; MOTTA M
      PRESENCE OF 5-ALPHA-REDUCTASE ISOZYMES AND AROMATASE IN HUMAN PROSTATE-CANCER CELLS AND IN BENIGN PROSTATE HYPERPLASTIC TISSUE

      The Prostate
    63. BAI GE; KASPER S; MATUSIK RJ; RENNIE PS; MOSHIER JA; KRONGRAD A
      ANDROGEN REGULATION OF THE HUMAN ORNITHINE DECARBOXYLASE PROMOTER IN PROSTATE-CANCER CELLS

      Journal of andrology
    64. Navone, NM; Logothetis, CJ; von Eschenbach, AC; Troncoso, P
      Model systems of prostate cancer: Uses and limitations

      CANCER AND METASTASIS REVIEWS
    65. YANG JP; FINKELMAN MA; CLARKE MW
      DETECTION OF PSP94 AND ITS SPECIFIC BINDING-SITES IN THE PROSTATE ADENOCARCINOMA CELL-LINE LNCAP

      The Journal of urology
    66. RISBRIDGER GP
      RECENT PROGRESS IN OUR UNDERSTANDING OF INHIBIN IN THE PROSTATE-GLAND

      Journal of Endocrinology
    67. DING VDH; MOLLER DE; FEENEY WP; DIDOLKAR V; NAKHLA AM; RHODES L; ROSNER W; SMITH RG
      SEX HORMONE-BINDING GLOBULIN MEDIATES PROSTATE ANDROGEN RECEPTOR ACTION VIA A NOVEL SIGNALING PATHWAY

      Endocrinology
    68. MORDENTE JA; CHOUDHURY MS; TAZAKI H; MALLOUH C; KONNO S
      HYDROLYSIS OF ANDROGEN RECEPTOR BY CATHEPSIN-D - ITS BIOLOGICAL SIGNIFICANCE IN HUMAN PROSTATE-CANCER

      British Journal of Urology
    69. BUTLER CM; HARRY JL; DEAKIN JE; COOPER DW; RENFREE MB
      DEVELOPMENTAL EXPRESSION OF THE ANDROGEN RECEPTOR DURING VIRILIZATIONOF THE UROGENITAL SYSTEM OF A MARSUPIAL

      Biology of reproduction
    70. BLOK LJ; DERUITER PE; BRINKMANN AO
      FORSKOLIN-INDUCED DEPHOSPHORYLATION OF THE ANDROGEN RECEPTOR IMPAIRS LIGAND-BINDING

      Biochemistry
    71. WANG LG; LIU XM; KREIS W; BUDMAN DR
      ANDROGEN ANTAGONISTIC EFFECT OF ESTRAMUSTINE PHOSPHATE (EMP) METABOLITES ON WILD-TYPE AND MUTATED ANDROGEN RECEPTOR

      Biochemical pharmacology
    72. KOLVENBAG GJCM; FURR BJA
      BICALUTAMIDE (CASODEX) DEVELOPMENT - FROM THEORY TO THERAPY

      The cancer journal from Scientific American
    73. FENTON MA; SHUSTER TD; FERTIG AM; TAPLIN ME; KOLVENBAG G; BUBLEY GJ; BALK SP
      FUNCTIONAL-CHARACTERIZATION OF MUTANT ANDROGEN RECEPTORS FROM ANDROGEN-INDEPENDENT PROSTATE-CANCER

      Clinical cancer research
    74. KOSHIDA K; ENDO Y; KOBAYASHI T; IMAO T; KONAKA H; KADONO Y; UCHIBAYASHI T; SASAKI T; NAMIKI M
      ENHANCED TUMORIGENIC AND METASTATIC POTENTIAL OF AN ANDROGEN-SENSITIVE HUMAN PROSTATE-CANCER CELL-LINE, LNCAP, BY INTRATESTICULAR INOCULATION IN SCID MICE

      International journal of oncology
    75. CHANG NS
      HYALURONIDASE ENHANCEMENT OF TNF-MEDIATED CELL-DEATH IS REVERSED BY TGF-BETA-1

      American journal of physiology. Cell physiology
    76. BLACKLEDGE GRP; COCKSHOTT ID; FURR BJA
      CASODEX(TM) (BICALUTAMIDE) - OVERVIEW OF A NEW ANTIANDROGEN DEVELOPEDFOR THE TREATMENT OF PROSTATE-CANCER

      European urology
    77. SKRYMA RN; PREVARSKAYA NB; DUFYBARBE L; ODESSA MF; AUDIN J; DUFY B
      POTASSIUM CONDUCTANCE IN THE ANDROGEN-SENSITIVE PROSTATE-CANCER CELL-LINE, LNCAP - INVOLVEMENT IN CELL-PROLIFERATION

      The Prostate
    78. RITCHIE CK; THOMAS KG; ANDREWS LR; TINDALL DJ; FITZPATRICK LA
      EFFECTS OF THE CALCIOTROPHIC PEPTIDES CALCITONIN AND PARATHYROID-HORMONE ON PROSTATE-CANCER GROWTH AND CHEMOTAXIS

      The Prostate
    79. SCHELLHAMMER PF; VENNER P; HAAS GP; SMALL EJ; NIEH PT; SEABAUGH DR; PATTERSON AL; KLEIN E; WAJSMAN Z; FURR B; CHEN YS; KOLVENBAG GJCM
      PROSTATE-SPECIFIC ANTIGEN DECREASES AFTER WITHDRAWAL OF ANTIANDROGEN THERAPY WITH BICALUTAMIDE OR FLUTAMIDE IN PATIENTS RECEIVING COMBINED ANDROGEN BLOCKADE

      The Journal of urology
    80. THOMAS TZ; WANG H; NICLASEN P; OBRYAN MK; EVANS LW; GROOME NP; PEDERSEN J; RISBRIDGER GP
      EXPRESSION AND LOCALIZATION OF ACTIVIN SUBUNITS AND FOLLISTATINS IN TISSUES FROM MEN WITH HIGH-GRADE PROSTATE-CANCER

      The Journal of clinical endocrinology and metabolism
    81. MOWSZOWICZ I; MESTAYER C
      ANDROGEN RECEPTOR GENE-MUTATIONS - POSSIB LE INVOLVEMENT IN PROSTATE ADENOCARCINOMA

      Bulletin du cancer
    82. DOESBURG P; KUIL CW; BERREVOETS CA; STEKETEE K; FABER PW; MULDER E; BRINKMANN AO; TRAPMAN J
      FUNCTIONAL IN-VIVO INTERACTION BETWEEN THE AMINO-TERMINAL, TRANSACTIVATION DOMAIN AND THE LIGAND-BINDING DOMAIN OF THE ANDROGEN RECEPTOR

      Biochemistry
    83. ZHENG JP; RUDRAGANGULY N; MILLER GJ; MOFFATT KA; COTE RJ; ROYBURMAN P
      STEROID-HORMONE INDUCTION AND EXPRESSION PATTERNS OF L-PLASTIN IN NORMAL AND CARCINOMATOUS PROSTATE TISSUES

      The American journal of pathology
    84. WANG LG; LIU XM; KREIS W; BUDMAN DR
      INVOLVEMENT OF PROSTATE-SPECIFIC ANTIGEN IN THE STIMULATION OF LNCAP CELL GROWTH

      Oncology Reports
    85. MORA GR; MAHESH VB
      AUTOREGULATION OF ANDROGEN RECEPTOR IN RAT VENTRAL PROSTATE - INVOLVEMENT OF C-FOS AS A NEGATIVE REGULATOR

      Molecular and cellular endocrinology
    86. WILSON CM; MCPHAUL MJ
      A-FORM AND B-FORM OF THE ANDROGEN RECEPTOR ARE EXPRESSED IN A VARIETYOF HUMAN TISSUES

      Molecular and cellular endocrinology
    87. KUIL CW; BRINKMANN AO
      ANDROGENS, ANTIANDROGENS AND ANDROGEN RECEPTOR ABNORMALITIES

      European urology
    88. FURR BJA
      THE DEVELOPMENT OF CASODEX(TM) (BICALUTAMIDE) - PRECLINICAL STUDIES

      European urology
    89. WEBBER MM; BELLO D; QUADER S
      IMMORTALIZED AND TUMORIGENIC ADULT HUMAN PROSTATIC EPITHELIAL-CELL LINES - CHARACTERISTICS AND APPLICATIONS .1. CELL MARKERS AND IMMORTALIZED NONTUMORIGENIC CELL-LINES

      The Prostate
    90. FURR BJA; TUCKER H
      THE PRECLINICAL DEVELOPMENT OF BICALUTAMIDE - PHARMACODYNAMICS AND MECHANISM OF ACTION

      Urology
    91. SCHER HI; ZHANG ZF; NANUS D; KELLY WK
      HORMONE AND ANTIHORMONE WITHDRAWAL - IMPLICATIONS FOR THE MANAGEMENT OF ANDROGEN-INDEPENDENT PROSTATE-CANCER

      Urology
    92. DAI JL; MAIORINO CA; GKONOS PJ; BURNSTEIN KL
      ANDROGENIC UP-REGULATION OF ANDROGEN RECEPTOR CDNA EXPRESSION IN ANDROGEN-INDEPENDENT PROSTATE-CANCER CELLS

      Steroids
    93. DONDI D; MORETTI RM; MARELLI MM; MOTTA M; LIMONTA P
      GROWTH-FACTORS IN STEROID-RESPONSIVE PROSTATIC TUMOR-CELLS

      Steroids
    94. BARRACK ER
      ANDROGEN RECEPTOR MUTATIONS IN PROSTATE-CANCER

      The Mount Sinai journal of medicine
    95. KUIL CW; MULDER E
      DEOXYRIBONUCLEIC ACID-BINDING ABILITY OF ANDROGEN RECEPTORS IN WHOLE CELLS - IMPLICATIONS FOR THE ACTION OF ANDROGENS AND ANTIANDROGENS

      Endocrinology
    96. KLUS GT; NAKAMURA J; LI JS; LING YZ; SON C; KEMPPAINEN JA; WILSON EM; BRODIE AMH
      GROWTH-INHIBITION OF HUMAN PROSTATE CELLS IN-VITRO BY NOVEL INHIBITORS OF ANDROGEN SYNTHESIS

      Cancer research
    97. HABIB FK; GRANT ES
      MOLECULAR AND CELLULAR BIOLOGY OF THE PROSTATE - IS IT CLINICALLY RELEVANT

      British Journal of Urology
    98. IDETA R; YEH SY; LEE YF; ADACHI K; TAKEDA H; SU CY; SALTZMAN A; CHANG CS
      GENE-EXPRESSION OF THE ANDROGEN REPRESSED RAT TR2 ORPHAN RECEPTOR - AMEMBER OF STEROID-RECEPTOR SUPERFAMILY

      Endocrine
    99. KUIL CW; BERREVOETS CA; MULDER E
      LIGAND-INDUCED CONFORMATIONAL ALTERATIONS OF THE ANDROGEN RECEPTOR ANALYZED BY LIMITED TRYPSINIZATION - STUDIES ON THE MECHANISM OF ANTIANDROGEN ACTION

      The Journal of biological chemistry
    100. KUIPER GGJM; BRINKMANN AO
      PHOSPHOTRYPTIC PEPTIDE ANALYSIS OF THE HUMAN ANDROGEN RECEPTOR - DETECTION OF A HORMONE-INDUCED PHOSPHOPEPTIDE

      Biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 14:21:12